To guide patients at risk for hereditary cancer through the information-gathering and testing process:
- Have them complete the quick and easy Hereditary Cancer Quiz or you may opt to use other tools designed to help you identify at risk patients. Learn more about these resources. Use the results to assist you in your evaluation of the patient.
- Discuss personal and/or family history and concerns about hereditary cancers with the patient. (Remind them that they can visit mySupport360™ for more information about hereditary cancer and its associated risks.)
- Discuss the benefits and limitations of genetic testing, and determine if the patient is an appropriate candidate. Brochures and videos are available to facilitate this conversation at MyriadPro.com.
- For testing, a small amount of blood will be drawn or a saliva sample is taken and sent to Myriad for analysis. It is important to obtain informed consent from the patient before submitting a sample to Myriad for testing.
Test results will be available in about two to three weeks.
After receiving the test results, you should discuss management options with your patient. If you order the Myriad myRisk® Hereditary Cancer Panel, applicable medical society guidelines will be included along with the results as par t of the myRisk Management Tool.
For more information about genetic testing, the results, management options and more, please visit MyriadPro.com.
